See Today's Golden Star Stocks 🔥 Free for 7 Days See Today's Golden Star Stocks 🔥 Free for 7 Days

News Digest / StockInvest.us

Author: StockInvest.us

08:11am, Monday, Aug 11, 2025

Compass Therapeutics Q2: Clinical wins drive R&D spend; $101M runway, key readouts in 2026

Compass Therapeutics, Inc. (NASDAQ: CMPX) - Q2 2025 snapshot Straight to the point: clinical progress is driving higher R&D spending. The company has a solid cash and securities position today but is burning cash faster year‑over‑year. Key trial readouts and program milestones are the main near‑t...

08:11am, Monday, Aug 11, 2025

Village Farms swings to profit on produce sale; Canadian cannabis drives margin recovery

08:10am, Monday, Aug 11, 2025

Rumble grows revenue 12% but posts $30.2M Q2 loss; cash strengthened by Tether

08:09am, Monday, Aug 11, 2025

AAON nears $1B backlog but ERP rollout, heavy capex and higher interest squeeze Q2 margins

08:08am, Monday, Aug 11, 2025

Kymera raises funds, holds ~$963M; Sanofi backs IRAK4, Gilead pays $40M as R&D burn climbs

08:08am, Monday, Aug 11, 2025

WW International Emerges from Chapter 11; New Equity, Lower Debt, Clinical Growth Buoys Margins

08:07am, Monday, Aug 11, 2025

Immunovant ramps IMVT‑1402 trials, burns cash but has $599M runway to 2027 GD readout

08:06am, Monday, Aug 11, 2025

Apogee's APG777 shows strong Phase 2 results; well-funded but burning cash fast

A

08:05am, Monday, Aug 11, 2025

MAIA reports THIO progress, major partners but warns of cash strain and dilution

M

08:04am, Monday, Aug 11, 2025

Roivant Q3 operating loss widens as R&D and G&A surge; $4.5B liquidity, buybacks continue

08:03am, Monday, Aug 11, 2025

Karyopharm cuts 20% of staff, pursues strategic and financing options amid cash crunch

08:02am, Monday, Aug 11, 2025

Array Digital pivots to towers and spectrum after $2.63B T‑Mobile sale, declares $23 dividend

08:01am, Monday, Aug 11, 2025

TDS posts weaker revenue but stronger cash flow after Array/T-Mobile deal

08:00am, Monday, Aug 11, 2025

Sphere posts Q2 GAAP profit on $346M MSGN debt gain; Sphere growth offsets MSGN weakness

S

07:04am, Monday, Aug 11, 2025

Yum China Q2: Modest sales and margin gains, Meituan loss and tax audit risk

«
1
2
...
64
65
66
67
68
69
70
...
296
297
»